Memiontec eyes doubling market cap by 2026 with sights set on regional expansion
WATER treatment company Memiontec had a rough start as a listed company, launching its initial public offering (IPO) on the Singapore Exchange in February 2020 – just as the Covid-19 pandemic was unravelling.
In a recent interview with The Business Times, Memiontec’s chief executive Tay Kiat Seng recalled how the company had to cut its public float and settle for a lower price-to-earnings ratio because of poor market conditions and cautious investor sentiment. The group had also been hoping for a public float of 20 to 25 per cent, but was forced to trim this to 17 to 20 per cent.
Tay said the company “bit the bullet” and forged ahead with the listing anyway. But its problems did not end there, as the company’s order book and demand for its offerings were hit.
TRENDING NOW
Think twice about rebuilding that old landed property into a super-big house to max out GFA
SpaceX’s US$1.75 trillion IPO: How retail investors, including those in Singapore, can buy shares
Private equity giant Carlyle can grow bigger but needs to stay on its toes: co-founder David Rubenstein
Battle for Asia’s ultra-rich: ‘Singapore can’t afford to keep losing clients to Dubai, Hong Kong’